Allogeneic hematopoietic stem cell transplantation in ERCC6L2 disease. [PDF]
Abstract The hallmark of ERCC6L2 disease (ED) is a highly penetrant progression from bone marrow failure to erythroid-predominant, TP53-mutated myeloid malignancy with a dismal prognosis. Allogeneic hematopoietic stem cell transplant (HSCT) remains the only potentially curative option, but concerns exist ...
Hakkarainen M +36 more
europepmc +5 more sources
The Outcomes of Myeloid Sarcoma in 64 Pediatric Patients and the Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Treatment Results [PDF]
Background: Myeloid sarcoma (MS) is a malignant extramedullary tumor that occurs in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia (CML).
Magdalena Samborska +31 more
doaj +2 more sources
A study on some factors affecting CMV reactivation in allogeneic hematopoietic stem cells transplantation [PDF]
Background: In developing countries, cytomegalovirus (CMV) seropositivity has been widely propagated. Following hematopoeitic stem cell transplantation, the apparent risk of CMV reactivation increases.
Metwally Metwally +4 more
doaj +1 more source
Comorbidity Index in Predicting Toxicity and Mortality Risk among patient Undergoing Hematopoietic Stem Cell Transplantation [PDF]
: Despite current improvement in supportive care, mortality after hematopoietic stem cell transplantation remains high. Caring for patients undergoing hematopoietic stem cell transplantation is one of the most challenging in nursing subspecialities. Aim:
Dina Mohamed Maarouf +3 more
doaj +3 more sources
Allogeneic hematopoietic stem-cell transplantation for myelofibrosis [PDF]
Myelofibrosis is one of the Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms with heterogeneous clinical course. Though many treatment options, including Janus kinase (JAK) inhibitors, have provided clinical benefits and improved survival, allogeneic hematopoietic stem-cell transplantation (AHSCT) remains the only potentially curative
Lining Zhang, Fan Yang, Sizhou Feng
openaire +3 more sources
Optimizing Allogeneic Grafts in Hematopoietic Stem Cell Transplantation [PDF]
AbstractAllogeneic hematopoietic stem cell transplantation (allo-HSCT) is widely used in the treatment of hematological diseases. It is well known that allogeneic grafts play a key role in predicting transplantation prognosis. Hematopoietic stem cells (HSCs) are a functional part of grafts and are capable of reconstructing hematopoiesis and immunity ...
Zheng-Li Xu, Xiao-Jun Huang
openaire +3 more sources
Allogeneic hematopoietic stem cell transplantation in Tunisia [PDF]
In 1998, the Tunisian team of the 'Centre National de Greffe de Moelle Osseuse' initiated allogeneic hematopoietic SCT (AHSCT) in Tunisia. As of June 2007, information was collected about 299 patients with a first AHSCT and 12 additional retransplants. The median age was 19 years (range 2-49 years). The main indications were aplastic anemia (n=106, 36%)
T, Ben Othman +7 more
openaire +2 more sources
Donation and transplantation of allogeneic hematopoietic stem cells [PDF]
Only 30% of patients with indications for a transplant have a matched related donor; the remaining 70% seek an unrelated donor on the world’s registry. Nonwhite Canadians have a particularly low likelihood of finding a match.1,2 Appendix 1 lists common indications for transplant (available at ...
Ilana, Kopolovic, Robert, Turner
openaire +2 more sources
Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation [PDF]
Allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective treatment for selected hematological malignancies. Its curative potential is largely mediated by an immune-mediated destruction of malignant cells by donor lymphocytes termed graft-versus-leukemia (GVL) effect.
Baron, Frédéric, Beguin, Yves
openaire +3 more sources
Allogeneic Hematopoietic Stem Cell Transplantation [PDF]
Acute complications such as veno-occlusive disease of the liver, acute and chronic graft-vs-host disease (GVHD), and infectious conditions remain major obstacles for the success of allogeneic hematopoietic stem cell transplantation (HSCT). Progress in allogeneic HSCT depends on several factors, including the adequate prevention and management of ...
Imad A, Tabbara +3 more
openaire +2 more sources

